Trial site
Lifespan Cancer Institute
- 12running trials
- 7closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Prostate cancer5 trials
- Childhood cancers4 trials
- Sarcoma3 trials
- Bladder cancer2 trials
- Lung cancer2 trials
- Melanoma2 trials
- Metastatic breast cancer2 trials
- Brain metastases1 trial
- Chronic lymphocytic leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Endometrial cancer1 trial
- Gastric and oesophageal cancer1 trial
- and 4 more
- Phase
- Phase 28 trials
- Phase 1/25 trials
- Phase 33 trials
- Phase 12 trials
- Status
- Active, not recruiting6 trials
- Recruiting6 trials
- Completed3 trials
- Terminated2 trials
- Withdrawn2 trials
- Lead sponsor
- Brown University5 trials
- Eli Lilly and Company5 trials
- Regeneron Pharmaceuticals3 trials
- Dana-Farber Cancer Institute2 trials
- Hoffmann-La Roche1 trial
- and 3 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
CAMPFIRE: A Study of Abemaciclib (LY2835219) in Participants With Ewing's Sarcoma
Active, not recruiting
Recruiting
Genomically Profiling, Collecting, Archiving and Distributing Hematologic Malignancy Specimens
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers2 recruiting
- Prostate cancer2 recruiting
- Kidney cancer1 recruiting
- Lung cancer1 recruiting
- Melanoma1 recruiting
- Myelodysplastic syndromes1 recruiting
Closed trials
Withdrawn
Terminated
Targeting Androgen Signaling in Urothelial Cell Carcinoma - Neoadjuvant
Withdrawn
Terminated
Completed
Completed
CASCARA: Castration Sensitive Carboplatin, Cabazitaxel and Abiraterone
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026